The latest clinical trial to be added to Join Dementia Research is ENGAGE, from Biogen Inc. Part of an international study, it is looking to determine whether a new medication called Aducanumab, can slow progression of early Alzheimer’s disease, as well as investigating whether it’s safe to use in patients.

Researchers are looking for volunteers aged 50-85 and those who are experiencing problems with memory or thinking may be eligible to take part. Participation will involve one or two site visits each month and telephone interviews for up to four years. The study will include questionnaires and interviews, physical examinations, MRI and PET scans, and other tests to monitor health. Sites are opening across England and Scotland.

Professor Craig Ritchie is Professor of the Psychiatry of Ageing at the University of Edinburgh and Chief Investigator in the ENGAGE study. He tells us more about the study in this video, and why dementia research in general is so important:



Martin-In-GardenYou can see if you are eligible for this study, and others, by logging into your Join Dementia Research account.

Not yet registered with Join Dementia Research?  Why not sign up today?